Leads in microbio culture media production
July 11, 2011 | Monday | News
RANK 18
Revenue 56.25 Crore
|
HiMedia
Laboratories |
CEO: Dr GM Warke
|
Business: Manufacturer of
media products for microbiology, immunology and serology
|
Start-up Year: 1976
|
Address: A-406, Bhaveshwar Plaza,
LBS Marg, Mumbai-400 086
Tel: +91-22-25003747 /
1607 / 0653
Fax: +91-022-25005764 /
2468
Website: www.himedialabs.com |
HiMedia is showing continuous growth
in the reagents sector and this has helped it reach revenue worth
`56.25 crore in this fiscal

HiMedia Laboratories is considered to be
amongst the few companies in India to possess high-technology know-how
for manufacturing of microbiological culture media. During the fiscal
year 2010-11, the company clocked an estimated biotech revenue of
`56.25 crore when compared with `45 crore in the previous year.
HiMedia produces HiVeg Peptones (hydrolysates prepared from non-animal
sources, such as wheat, corn and soy), which are manufactured by its
sister company, Warkem Biotech. The manufacturing plant had recently
been overhauled in order to meet global needs, particularly with the
increasing demand for non-animal protein hydrolysates. This apart, the
company launched comprehensive and easy-to-perform kits for soil and
water analysis for farmers and agriculturists. The company also
launched kits for testing adulteration in milk and detection of arsenic
in water, a kit to detect mastitis in cows (in collaboration with
Shree Chitra Tirunal Institute, Kerala) and cost-effective kits for
detection of sickle cell anemia (screening as well as confirmation).
HiMedia also made an entry into the stem cell and primary cell markets
wherein cells and media are made available to scientists at an
affordable cost. Scaling up of production of stem cells, primary cells
and their media is on the cards. Presently these are being imported and
by 2011 the company is looking to make these available in India.
HiMedia is a partner in supplying culture media to the National
Biodiversity Screening Program, which was introduced two years ago by
the Department of Biotechnology, to screen the rich and diverse flora
and fauna in India. During the outbreak of the H1N1 pandemic, HiMedia
launched the swine flu transport kit. These kits were
manufactured at the company’s Nasik facility. For this particular kit,
the company acquired six new biosafety level type 2 cabinets, and
bought appropriate filtration equipments.